Delivering the fruits of biotechnology to the developing world: Institute for Global Health sponsors global health forum, February 18-21

Leaders from governments, biotechnology companies, and multi-lateral agencies from around the world will gather in Carmel Valley, CA, February 18-21 to study how best to promote development of drugs and vaccines for the world's poorest countries. This Global Health Forum: "Creating Global Markets for Orphan Drugs & Vaccines: A Challenge for Public/Private Partnership," will be sponsored by the Institute for Global Health, of the University of California, San Francisco, and UC Berkeley.

Although the forum is closed to the press and the public, its participants will publish a set of conclusions and recommendations for action. They will discuss these recommendations at a press briefing in San Francisco, Tuesday, February 22.

As the biotechnology and vaccine industries have blossomed in recent decades, they have focused predominantly on diseases affecting the world's richest countries. Diseases that plague poor countries, such as malaria and sleeping sickness, have been largely ignored, said Dr. Richard Feachem, PhD, DSc(Med), founding director of the Institute for Global Health, and a professor of international health at UCSF and UC Berkeley.

"Modern biomedical science and biotechnology are beginning to deliver fantastically powerful new drugs and new vaccines. We must find ways to bring the fruits of medical science to all people in the world who could benefit from them. If we fail, the consequences will be catastrophic," he said.

Without a more concerted effort, the epidemics developing countries are now facing will reach catastrophic proportions, Feachem said. "In a few years, malaria will be untreatable, and HIV will have caused devastation in Asia as it has already in Africa," he said. Malaria parasites are quickly becoming resistant and there are no new drugs in the development pipeline, and HIV vaccines that low income countries can afford and use are still years away, he

Several public/private partnerships targeting individual diseas

Contact: Kevin Boyd
University of California - San Francisco

Page: 1 2 3

Related biology news :

1. More people are getting sick from eating fresh fruits
2. Middle-aged women who consume many fruits and vegetables are at much lower risk of cardiovascular disease
3. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
4. UK biotechnology business plan competition now open to students in the US and Canada
5. Plants for the future: A European vision for plant biotechnology towards 2025
6. University of Pittsburgh Medical Center acquires biotechnology firm Rheogene Inc.
7. Poll: NY residents split on biotechnology in food and agriculture
8. First company founded on UCF biotechnology formed
9. NASA biotechnology activities enhancing quality of life
10. Genetic engineering accelerates the impact of biotechnology on chemical production
11. Symposium to focus on ethical issues in biotechnology

Post Your Comments:

(Date:11/19/2015)... VIEW, Calif. , Nov. 19, 2015  Based ... market, Frost & Sullivan recognizes BIO-key with the 2015 ... Leadership. Each year, Frost & Sullivan presents this award ... product line catering to the needs of the market ... the product line meets and expands on customer base ...
(Date:11/17/2015)... , November 17, 2015 Paris ... 2015.   --> Paris from 17 ... DERMALOG, the biometrics innovation leader, has invented the first ... fingerprints on the same scanning surface. Until now two different ... Now one scanner can capture both on the same ...
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... 1, 2015  An interventional radiology technique shows promise for ... results of a study being presented today at the annual ... (RSNA). --> ... by interventional radiologists as a way to stop bleeding in ... a means of treating obesity is new. Mubin ...
(Date:11/30/2015)... includes an MPP licen ... niversity , s Solid Drug Nanoparticle (SDN) Technology ; ... up through cost cuts of priority ... based anywhere in the world will have the right to make, use and distribute ... where licensees based anywhere in the world will have the right to make, use ...
(Date:11/30/2015)... 2015 Harvard Apparatus Regenerative Technology, Inc. ... developing bioengineered organ implants for life-threatening conditions, today ... NASDAQ Stock Market that it has regained compliance ... noted that as a result of the closing ... $1.00 per share for more than ten consecutive ...
(Date:11/30/2015)... Md. , Nov. 30, 2015 ... development company committed to the fostering and monetization ... the current and prospective initiatives designed to create ... Chief Executive Officer of Spherix. "Based on published ... future licensees exceeds $50 billion and Spherix will ...
Breaking Biology Technology:
Cached News: